Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Non Operating Income (2022 - 2025)

TriSalus Life Sciences' Non Operating Income history spans 4 years, with the latest figure at -$71000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 30.39% year-over-year to -$71000.0; the TTM value through Dec 2025 reached -$456000.0, down 46.15%, while the annual FY2025 figure was -$456000.0, 46.15% down from the prior year.
  • Non Operating Income reached -$71000.0 in Q4 2025 per TLSIW's latest filing, up from -$94000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $3.5 million in Q1 2022 to a low of -$349000.0 in Q4 2022.
  • Average Non Operating Income over 4 years is $292640.4, with a median of -$42000.0 recorded in 2024.
  • The largest YoY upside for Non Operating Income was 68.32% in 2024 against a maximum downside of 705.26% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$349000.0 in 2022, then rose by 7.74% to -$322000.0 in 2023, then skyrocketed by 68.32% to -$102000.0 in 2024, then skyrocketed by 30.39% to -$71000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Non Operating Income are -$71000.0 (Q4 2025), -$94000.0 (Q3 2025), and -$40000.0 (Q2 2025).